Bicara Therapeutics Inc (BCAX) is 1.85% away from 50-day simple Moving Average despite all headwinds

Shaun Noe

Bicara Therapeutics Inc (NASDAQ: BCAX) established initial surge of 6.05% at $17.17, as the Stock market unbolted on Wednesday, before settling in for the price of $16.19 at the close. Taking a more long-term approach, BCAX posted a 52-week range of $7.80-$19.71.

Nevertheless, stock’s Earnings Per Share (EPS) this year is 37.54%. This publicly-traded company’s shares outstanding now amounts to $54.61 million, simultaneously with a float of $31.99 million. The organization now has a market capitalization sitting at $940.61 million. At the time of writing, stock’s 50-day Moving Average stood at $16.86, while the 200-day Moving Average is $13.47.

Bicara Therapeutics Inc (BCAX) Ownership Facts and Figures

Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Bicara Therapeutics Inc industry. Bicara Therapeutics Inc’s current insider ownership accounts for 41.60%, in contrast to 63.94% institutional ownership. According to the most recent insider trade that took place on Dec 22 ’25, this organization’s Chief Financial Officer sold 9,200 shares at the rate of 18.31, making the entire transaction reach 168,492 in total value, affecting insider ownership by 145,355.

Bicara Therapeutics Inc (NASDAQ: BCAX) Trading Performance Indicators

Let’s observe the current performance indicators for Bicara Therapeutics Inc (BCAX). It’s Quick Ratio in the last reported quarter now stands at 14.14.

In the same vein, BCAX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.23, a figure that is expected to reach -0.69 in the next quarter, and analysts are predicting that it will be -3.04 at the market close of one year from today.

Technical Analysis of Bicara Therapeutics Inc (BCAX)

Now, what If we examine the latest scores posted by [Bicara Therapeutics Inc, BCAX]. During the last 5-days, its volume was lower the volume of 0.55 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 35.65% While, its Average True Range was 51.69.

Raw Stochastic average of Bicara Therapeutics Inc (BCAX) in the period of the previous 100 days is set at 73.02%, which indicates a major rise in contrast to 44.22% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.84 that was lower than 1.00 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.